Revance Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
70%
€17.50
Target price
31.12.25
€30.00
Performance (%)
76.00%
End price
05.05.23
€30.80
Summary
This prediction ended on 05.05.23 with a price of €30.80. With a performance of 76.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.192% | 3.121% | 16.828% |
| iShares Nasdaq 100 | 1.245% | 5.051% | 31.022% |
| iShares Nikkei 225® | -0.992% | 1.101% | 9.804% |
| iShares S&P 500 | 0.154% | 2.864% | 26.511% |
According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year